Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.

Macrophages synthesize and secrete apolipoprotein E (apoE) constitutively. This process is upregulated under conditions of cholesterol loading. The response to cholesterol is antiatherogenic as it is believed to promote cholesterol efflux from the artery wall. The concentration of lactosyl ceramide...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Garner, B, Mellor, H, Butters, T, Dwek, R, Platt, F
Natura:	Journal article
Lingua:	English
Pubblicazione:	2002

Documenti analoghi

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice.
di: Garner, B, et al.
Pubblicazione: (2002)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
di: Brett Garner, et al.
Pubblicazione: (2002-02-01)

Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells
di: John K. Bielicki, et al.
Pubblicazione: (1999-01-01)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
di: Butters, T, et al.
Pubblicazione: (2003)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
di: Butters, T, et al.
Pubblicazione: (2000)

Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis.
di: Mellor, H, et al.
Pubblicazione: (2004)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
di: Jeyakumar, M, et al.
Pubblicazione: (2002)

New developments in treating glycosphingolipid storage diseases.
di: Platt, F, et al.
Pubblicazione: (2005)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
di: Andersson, U, et al.
Pubblicazione: (2000)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
di: Priestman, D, et al.
Pubblicazione: (2008)

Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice
di: Elias N. Glaros, et al.
Pubblicazione: (2008-08-01)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
di: van der Spoel, A, et al.
Pubblicazione: (2002)

Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
di: Platt, F, et al.
Pubblicazione: (2000)

Glycosphingolipid disorders of the brain.
di: Boomkamp, S, et al.
Pubblicazione: (2008)

Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis
di: Butters, T, et al.
Pubblicazione: (2000)

The apo E gene knockout mouse as a model to study the potential atherogenic properties of glycosphingolipids
di: Garner, B, et al.
Pubblicazione: (2003)

Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
di: Boomkamp, S, et al.
Pubblicazione: (2010)

Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages
di: Eija Nissilä, et al.
Pubblicazione: (2018-11-01)

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling.
di: Neville, D, et al.
Pubblicazione: (2004)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
di: Silk, J, et al.
Pubblicazione: (2005)

Walnut oil increases cholesterol efflux through inhibition of stearoyl CoA desaturase 1 in THP-1 macrophage-derived foam cells
di: Gillies Peter J, et al.
Pubblicazione: (2011-08-01)

THP-1 macrophage cholesterol efflux is impaired by palmitoleate through Akt activation.
di: Jenika D Marshall, et al.
Pubblicazione: (2020-01-01)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
di: Gadola, S, et al.
Pubblicazione: (2006)

Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells
di: Reijiro Arakawa, et al.
Pubblicazione: (2000-12-01)

Effects of cellular cholesterol loading on macrophage foam cell lysosome acidifications⃞
di: Brian E. Cox, et al.
Pubblicazione: (2007-05-01)

Glycosphingolipids in endocytic membrane transport.
di: Sillence, D, et al.
Pubblicazione: (2004)

Recombinant Klotho protein enhances cholesterol efflux of THP-1 macrophage-derived foam cells via suppressing Wnt/β-catenin signaling pathway
di: Wei Liu, et al.
Pubblicazione: (2020-03-01)

Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.
di: Pei, B, et al.
Pubblicazione: (2011)

Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages
di: Anouar Hafiane, MSc, PhD, et al.
Pubblicazione: (2021-01-01)

Regulation of macrophage apolipoprotein E gene expression by cholesterol.
di: T Mazzone, et al.
Pubblicazione: (1989-07-01)

Introduction: Glycosphingolipids in cell biology and disease.
di: Sillence, D, et al.
Pubblicazione: (2004)

Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
di: Mellor, H, et al.
Pubblicazione: (2003)

FHL2 regulates THP-1 macrophage foaming through NF-κB signaling pathway
di: CHEN Weiwei, LIAO Huang, SHI Zhenhong, LUO Ying
Pubblicazione: (2024-02-01)

Ion Transport Modulators Differentially Modulate Inflammatory Responses in THP-1-Derived Macrophages
di: Steven C. Mitini-Nkhoma, et al.
Pubblicazione: (2021-01-01)

Modulator Effect of AT1 Receptor Knockdown on THP-1 Macrophage Proinflammatory Activity
di: Lourdes Nallely Acevedo-Villavicencio, et al.
Pubblicazione: (2024-05-01)

Substrate reduction therapy for glycosphingolipid storage disorders.
di: Lachmann, R, et al.
Pubblicazione: (2001)

Apoptotic modification of glycosphingolipids of human granulocytes
di: A. M. Tomin, et al.
Pubblicazione: (2012-09-01)

Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected].
di: Muindi, K, et al.
Pubblicazione: (2010)

Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport.
di: te Vruchte, D, et al.
Pubblicazione: (2004)

Hydroxychloroquine Effects on THP-1 Macrophage Cholesterol Handling: Cell Culture Studies Corresponding to the TARGET Cardiovascular Trial
di: Saba Ahmed, et al.
Pubblicazione: (2022-09-01)